Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

HYDROXYZINE PAM 100 MG CAP

Hydroxyzine Pamoate
$0.4402per EA
High Outlier

Strength

100 mg/1

Manufacturer

Teva Pharmaceuticals USA Inc.

NDC

00555032402

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

HYDROXYZINE PAMOATE

Approval Type

Generic (ANDA)

FDA Application

ANDA088488

On Market Since

7/1/1984

Pharmacological Classes

Antihistamine
Histamine Receptor Antagonists

Price History

1W

0.0%

1M

-0.4%

3M

+2.6%

6M

+7.5%

1Y

+5.0%

3Y

+10.8%

5Y

-5.1%

All

+76.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

NIGHTTIME COLD-FLU LIQUID
Generic
70000018402•Cardinal Health
$0.0094
per ML
NIGHT TIME COLD-FLU LIQUID
Generic
46122019840•AmerisourceBergen
$0.0106
per ML
FT NIGHTTIME COLD-FLU RLF LIQ
Generic
70677103201•Strategic Sourcing Services LLC
$0.0106
per ML
FT NIGHTTIME COLD-FLU RLF LIQ
Generic
70677103302•Strategic Sourcing Services LLC
$0.0106
per ML
FT NIGHT SEVERE COLD-FLU LIQ
Generic
70677103001•Strategic Sourcing Services LLC
$0.0129
per ML
NIGHTTIME COLD AND FLU LIQUID
Generic
70000018302•Cardinal Health
$0.0137
per ML
GS NIGHTTIME COLD-FLU LIQUID
Generic
00113033534•L. Perrigo Company
$0.0148
per ML
ALL-NITE COLD-FLU RELIEF LIQ
Generic
00904646509•Major Pharmaceuticals
$0.0148
per ML
NIGHT TIME COLD-FLU LIQUID
Generic
46122013634•AmerisourceBergen
$0.0148
per ML
NIGHT TIME COLD-FLU LIQUID
Generic
46122019834•AmerisourceBergen
$0.0148
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy